Paragon Care Ltd (ASX: PGC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Paragon Care Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Paragon Care Ltd (ASX: PGC)
Latest News

Earnings Results
Paragon Care (ASX: PGC) share price soars 5% on $8.3 million profit

Share Market News
ASX winners and losers from the Victorian budget

Share Market News
Here’s why the Paragon (ASX:PGC) share price has surged 19% today

Healthcare Shares
Why the Paragon Care share price is rocketing 83% today

Share Market News
Why these 3 ASX shares surged higher today

Share Fallers
Why ARB, OneVue, Origin Energy, & Paragon Care are tumbling lower

Share Market News
Why the Paragon share price has plummeted 19% today

Defensive Shares
3 healthcare ASX shares I’d buy for my portfolio
Dividend Payment History Data provided by Morningstar.
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
21 Mar 2022 | $0.0060 | 100.00% | Interim | 26 Apr 2022 |
13 Sep 2021 | $0.0100 | 100.00% | Final | 01 Oct 2021 |
21 Mar 2019 | $0.0110 | 100.00% | Interim | 26 Apr 2019 |
14 Sep 2018 | $0.0200 | 100.00% | Final | 12 Oct 2018 |
15 Mar 2018 | $0.0110 | 100.00% | Interim | 12 Apr 2018 |
07 Sep 2017 | $0.0190 | 100.00% | Final | 06 Oct 2017 |
09 Mar 2017 | $0.0110 | 100.00% | Interim | 06 Apr 2017 |
15 Sep 2016 | $0.0140 | 100.00% | Final | 06 Oct 2016 |
09 Mar 2016 | $0.0080 | 100.00% | Interim | 06 Apr 2016 |
27 Aug 2015 | $0.0080 | 100.00% | 18 Sep 2015 | |
05 Mar 2015 | $0.0060 | 100.00% | 31 Mar 2015 | |
08 Oct 2014 | $0.0075 | 100.00% | Final | 31 Oct 2014 |
07 Mar 2014 | $0.0050 | 100.00% | Interim | 31 Mar 2014 |
04 Oct 2013 | $0.0100 | 100.00% | Final | 31 Oct 2013 |
PGC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Paragon Care Ltd
Paragon Care Ltd is a medical device company. It is a provider of medical equipment, devices and consumables to the healthcare market. The company provides solutions to various healthcare markets that is Aged care; Hospital and Acute care;Primary Care; Eye Care; Storage Solutions; and E-Health.
PGC Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
16 May 2022 | $0.35 | $-0.02 | -5.41% | 649,787 | $0.37 | $0.37 | $0.35 |
13 May 2022 | $0.37 | $0.03 | 8.82% | 517,089 | $0.34 | $0.37 | $0.34 |
12 May 2022 | $0.34 | $-0.01 | -2.86% | 164,779 | $0.34 | $0.35 | $0.34 |
11 May 2022 | $0.35 | $0.00 | 0.00% | 28,097 | $0.34 | $0.35 | $0.34 |
10 May 2022 | $0.35 | $-0.01 | -2.78% | 445,059 | $0.35 | $0.37 | $0.34 |
09 May 2022 | $0.36 | $-0.02 | -5.26% | 242,102 | $0.37 | $0.37 | $0.36 |
06 May 2022 | $0.38 | $0.00 | 0.00% | 86,759 | $0.37 | $0.38 | $0.35 |
05 May 2022 | $0.38 | $0.00 | 0.00% | 23,355 | $0.38 | $0.38 | $0.38 |
04 May 2022 | $0.38 | $0.00 | 0.00% | 136,087 | $0.39 | $0.39 | $0.38 |
03 May 2022 | $0.39 | $0.01 | 2.63% | 80,585 | $0.40 | $0.40 | $0.38 |
02 May 2022 | $0.38 | $-0.04 | -9.64% | 360,175 | $0.42 | $0.42 | $0.36 |
29 Apr 2022 | $0.42 | $0.04 | 10.53% | 323,909 | $0.39 | $0.42 | $0.38 |
28 Apr 2022 | $0.38 | $0.02 | 5.48% | 276,488 | $0.37 | $0.38 | $0.36 |
27 Apr 2022 | $0.37 | $0.00 | 0.00% | 504,745 | $0.36 | $0.37 | $0.36 |
26 Apr 2022 | $0.37 | $-0.02 | -5.19% | 255,947 | $0.38 | $0.38 | $0.36 |
22 Apr 2022 | $0.39 | $0.02 | 5.41% | 132,765 | $0.38 | $0.39 | $0.38 |
21 Apr 2022 | $0.37 | $0.01 | 2.78% | 235,308 | $0.37 | $0.37 | $0.35 |
20 Apr 2022 | $0.36 | $-0.01 | -2.74% | 230,580 | $0.37 | $0.37 | $0.36 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
26 Apr 2022 | Shane Tanner | Buy | 19 | $7,200 |
Dividend Reinvestment Plan (DRP).
|
26 Apr 2022 | Mark Simari | Buy | 6 | $2,442 |
Dividend Reinvestment Plan (DRP).
|
26 Apr 2022 | Brent Stewart | Buy | 55 | $20,257 |
Dividend Reinvestment Plan (DRP).
|
20 Apr 2022 | Geoffrey Sam | Buy | 32 | $12,008 |
On-market trade.
|
04 Mar 2022 | Shane Tanner | Buy | 160 | $62,548 |
On-market trade.
|
01 Mar 2022 | Geoffrey Sam | Buy | 195 | $74,386 |
On-market trade.
|
01 Oct 2021 | Shane Tanner | Buy | 40 | $10,000 |
Dividend Reinvestment Plan (DRP).
|
01 Oct 2021 | Mark Simari | Buy | 15 | $3,914 |
Dividend Reinvestment Plan (DRP). As per announcement on 01/10/2021
|
01 Oct 2021 | Brent Stewart | Buy | 129 | $32,463 |
Dividend Reinvestment Plan (DRP).
|
01 Oct 2021 | Geoffrey Sam | Buy | 7 | $1,993 |
Dividend Reinvestment Plan (DRP).
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Shane Francis Tanner | Non-Executive DirectorNon-Executive Chairman | Dec 2005 |
Mr Tanner was one of the Co-Founders of Paragon Care Limited and has experience at both senior executive and board level, bringing more than 25 years experience in healthcare and strategy. Shane has orchestrated and been responsible for numerous small and large-scale acquisitions. He has also helped to establish and guide a number of businesses. Shane is currently Chairman of Guardian Alphabet Holdco Pty Ltd. Previously, Shane was CEO of Symbion Health, one of Australia's largest diagnostic businesses and Chairman of Vision Eye Institute. Cronos Australia Limited (CAU) Vision Eye Institute, Funtastic Limited, Rhythm Biosciences Limited He is a Member of Investment Review Committee.
|
Mr Philip (Phil) Nicholl | Executive Director | Nov 2019 |
Mr Nicholl is currently the CEO of one of Paragon's businesses, a company in the orthopaedics market in Australia and New Zealand. Mr Nicholl has experience in the medical devices industry having occupied senior executive roles for the companies including Stryker and Cochlear.
|
Mr Mark Anthony Simari | Non-Executive Director | Apr 2007 |
Mr Simari is an experienced professional in the health industry and has over 12 years Board experience in a range of organisations, including not for profits. Mark was the former Chief Executive Officer and Managing Director and Co- Founder of Paragon Care during his tenure (between 2008 and 2018). He was instrumental in Paragon Care becoming one of the largest independent healthcare suppliers in the Australian and New Zealand market, creating a healthcare platform spanning across capital equipment, consumables, devices and service and maintenance. Mark has also held various directorship positions in other companies such as Tali Digital Limited, Social Investment Australia Limited, Sage Capital Group Pty Ltd, InterPrac Financial Planning Pty Ltd and DKN Financial Group. Mark is presently the Chairman of Unisono Pty Limited and Akita Consulting. He also holds advisory roles with Fruitlink Pty Ltd. He is Chair of Risk Committee, Member of Investment Committee.
|
Mr Mark Robert Hooper | Chief Executive OfficerManaging Director | Apr 2022 |
Mr Hooper has career in healthcare sector in the Australian market. Mr Hooper was appointed Managing Director & CEO of Sigma in August 2010 and over the past decade he has led the Sigma business through a divestment of the Pharmaceutical division and several acquisitions, as well as an internal transformation project to generate operating efficiencies and the renewal of Sigma's national distribution centre network. He was also Chair of the Wholesaler industry body (NPSA) from October 2015 to August 2020. Prior to joining Sigma, Mr Hooper had a range of experience in finance, commercial and operational roles, primarily in the mining and pharmaceutical industries. Mr Hooper is a former Chief Financial Officer and Executive Director of PaperlinX Limited. From 2006 to 2008, Mr Hooper was the Chief Financial Officer and Chief Operating Officer for the Pharmacy and Consumer business for Symbion Health Limited. Prior to that he was the Chief Financial Officer of Sigma from 2001 to 2006.
|
Mr John Walstab | Executive Director | Feb 2022 |
Mr Walstab was the Group Managing Director and CEO of Quantum Health Group and he has nearly 40 years' experience in medical equipment distribution across Australia and Asia. Mr Walstab was the founder of InSight Oceania (Quantum Healthcare) and he joined the Board of Quantum Health Group in 2003. Prior to that, Mr Walstab was the Managing Director of ATL Australia (Philips Medical Systems ANZ).
|
Mr Geoffrey Joseph Sam | Non-Executive Director | Jun 2016 |
Mr Sam has held numerous ASX listed board positions including Chairman of Money 3, Director of Hutchison's Childcare Services and Managing Director of Nova Health. Prior to his appointments to ASX listed companies, Geoffrey undertook numerous Chief Executive positions at Adelaide based hospitals. He is currently the Co-Founder and Director of HealtheCare Australia Pty Ltd, a privately owned health care company comprising a portfolio of 35 hospitals and a community nursing and rehabilitation business. He is the Chairman of Investment Review Committee and Member of Risk Committee
|
Mr Alan Timothy McCarthy | Non-Executive Director | Feb 2022 |
Mr McCarthy was a Non-Executive Director of Quantum Health Group and he has over 30 years' experience spanning public health and private health services across the Asia Pacific region. Mr McCarthy's prior roles include the CEO at Alpenglow Australia and New Zealand, Managing Director of Philips (ANZ), Vice-President at CareFusion, Country Manager ANZ at Cardinal Health and General Manager of Diagnostic Imaging at Mayne Health/Health Care of Australia. Mr McCarthy is currently a Non-Executive Director of Q Scan and RHC Group Ltd and the CEO of AdvaHealth Solutions.
|
Mr Brent Stewart | Non-Executive Director | May 2018 |
Mr Stewart is an experienced company executive and director having occupied numerous senior executive and board roles over the past 25 years. He established and grew a company in Australia and New Zealand (Market Equity Pty Ltd) before selling to a large multinational group (Aegis PLC). Brent has a long association with various segments of the healthcare sector in Australia and internationally. Currently, Brent occupies Non-Executive roles at HBF Health Ltd, Etherington Inc and Argonaut Ltd. He is a Member of the Risk Committee.
|
Ms Melanie Jaye Leydin | Company Secretary | Jun 2018 |
-
|
Stephen Munday | Chief Financial Officer |
-
|
|
Melanie Jaye Leydin | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Perpetual Corporate Trust Ltd | 50,418,386 | 14.92% |
First Samuel Ltd Acn 086243567 <Anf Its Mda Clients A/C> | 24,885,164 | 7.36% |
Berne No 132 Nominees Pty Ltd <737539 A/C> | 16,717,541 | 4.95% |
Citicorp Nominees Pty Limited | 16,329,042 | 4.83% |
Buttonwood Nominees Pty Ltd | 5,678,195 | 1.68% |
Jmt Investment Group Vic Pty Ltd <John Turner Super Fund A/C> | 5,000,000 | 1.48% |
Negroni Holdings Pty Ltd <The Dfn A/C> | 4,727,531 | 1.40% |
Mr Paul Andrew Schollum & Mrs Katrina Maree Caldwell & Mrs Deborah Anne Moss | 4,717,320 | 1.40% |
Shemozel Pty Ltd <Shemozel A/C> | 4,561,256 | 1.35% |
HSBC Custody Nominees (Australia) Limited | 4,506,273 | 1.33% |
Jmt Investment Group Vic Pty Ltd | 4,240,000 | 1.25% |
Newmeld Pty Ltd <Newmeld Super Fund A/C> | 4,078,172 | 1.21% |
Heath Nominees (Aust) Pty Ltd <The Heath Family A/C> | 3,782,924 | 1.12% |
Grills Investments Pty Ltd <Grills Discretionary Trust> | 3,773,585 | 1.12% |
Mrs Michelle Stewart & Mr Brent Michael Stewart <Brent Stewart Super A/C> | 3,246,334 | 0.96% |
Mr Paul Andrew Schollum & Mrs Katrina Maree Caldwell & Mrs Deborah Anne Moss (I) | 3,106,538 | 0.92% |
Lora Falls Pty Ltd <The Fehrmann Family Trust> | 3,000,000 | 0.89% |
Heath Super (Aust) Pty Ltd <Heath Super Fund A/C> | 2,870,092 | 0.85% |
John Keith Radley & Paul Andrew Schollum <Paul Schollum Family> | 2,595,540 | 0.77% |
Grayson Nominees Pty Ltd <Grayson Investment A/C> | 2,500,000 | 0.74% |